Posters & Presentations

Filter Posters & Presentations

Oral cholate challenge test stratifies hepatotoxicity risk after liver-directed therapy for hepatocellular carcinoma

M. Hoteit, M.P. McRae, J.C. Imperial, G.T. Everson | EASL Congress May 2026

Noninvasive Quantification of Liver Function and Portal-Systemic Shunting Distinguishes Differences between Child-Pugh A5 and A6 Cirrhosis

N. Chalasani, M.L. Shiffman, T.R. Morgan, M.D. Leise, M.P. McRae, J.C. Imperial, G.T. Everson | Baveno VIII Consensus Workshop

Noninvasive Quantification of Portal-Systemic Shunting: A New Approach to Assessment of the Portal Hypertension and the Portal Circulation

J.C. Imperial, O. Etzion, T. Heller, E. Levy, D. Kleiner, R. Ali, M.P. McRae, G.T. Everson | Baveno VIII Consensus Workshop

The Quantitative HepQuant DuO Test Uncovers the Functional Heterogeneity of Advanced Chronic Liver Disease

J.C. Imperial, M.P. McRae, and G.T. Everson | 9th Annual MASH Drug Development Summit

Simultaneous quantification of function of native human liver and porcine liver in an extracorporeal circuit derived from the blood concentrations of intravenously injected 13C-cholate

Abraham Shaked, Michael P. McRae, Joanne C. Imperial, Leanne Lanieri, Alexander Sagar, Kathryn C. Stiede, Kirsten G. Swenson, Peter Friend, Gregory T. Everson | DDW 2025 Presentation

Quantifying Liver Function by Cholate Clearance in Extracorporeal Circuits with a Genetically Modified Porcine Liver and Brain-Dead Human Decedent

A. Shaked, M.P. McRae, L. Lanieri, A. Sagar, K.C. Stiede, K.G. Swenson, P. Friend, G.T. Everson | EASL May 2025

HepQuant DuO for Quantifying Liver Function and Physiology in the Clinic: Diagnostic Performance for Esophageal Varices in Patients with Treated and Active Chronic Hepatitis C

M.L. Shiffman, T. Hassanein, J.C. Imperial, M.P. McRae and G.T. Everson for the HALT-C and SHUNT-V Investigators | Global Hepatitis Summit | March 2025

Independent analysis of early clinical practice experience with the HepQuant DuO test

U.B. Patel, R. Nakarani, B.Patel | DDW 2025 | May 2025

Initial Clinical Experience with the HepQuant DuO Test: Results from the 2023–2024 Early Access Program

S. Gordon, J. Burton, B. Patel, J.C. Imperial, M.P. McRae, G.T. Everson | Liver Connect | March 2025

Poster of Distinction: Pilot Study of a Model Based on Noninvasive Assessments of Portal-Systemic Shunting (HepQuant DuO)

O. Etzion, T. Heller, Elliot Levy, David Kleiner, Rabab Ali, M.P. McRae, G.T. Everson | AASLD | November 2024

Cost-Effectiveness of the HepQuant DuO Test for the Management of Patients at Risk for Large Esophageal Varices

S. Chavan, M.P. McRae, Kelly R. Pitts, G.T. Everson | AASLD | November 2024